INNOVATE

INVESTIGATE

EDUCATE

IMPROVED OUTCOMES

Our model to defy heart disease

We work to identify, develop and promote the latest advancements in the treatment of heart and vascular disease. By covering all aspects of the research continuum, we’re able to accelerate the speed with which breakthrough therapies reach patients through doctors, improving survival rates and quality of life, faster.

Advancements

Drug-eluting Stents »

Drug-eluting stents (DES) are small mesh tubes that keep clogged arteries open after an angioplasty and slowly release medicine to help reduce re-blockage.

TAVR »

Transcatheter aortic valve replacement (TAVR) is a less invasive heart valve replacement procedure, performed through a catheter, which allows patients to avoid open-heart surgery.

Bioresorbable Stents »

The bioresorbable stent is an exciting new advancement currently in testing that holds open narrowed arteries and then “disappears” as it is naturally absorbed into the body.


The field of interventional cardiology has made great strides in developing innovative treatments that have changed the lives of heart patients around the world. These are just some of the major advancements in which CRF played a role in the last two decades.

Your gift goes to help save and improve the lives of people living with heart and vascular disease. Find out more or:

For naming opportunities or to support CRF’s mission contact info@crf.org.